Cargando…
Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
Gaucher disease (GD) is characterized by accumulation of glucosylceramide in lysosomes due to mutations in the GBA1 gene encoding the lysosomal hydrolase β-glucocerebrosidase (GCase). The disease has a broad spectrum of phenotypes, which were divided into three different Types; Type 1 GD is not asso...
Autores principales: | Bendikov-Bar, Inna, Maor, Gali, Filocamo, Mirella, Horowitz, Mia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547170/ https://www.ncbi.nlm.nih.gov/pubmed/23158495 http://dx.doi.org/10.1016/j.bcmd.2012.10.007 |
Ejemplares similares
-
Parkin-mediated ubiquitination of mutant glucocerebrosidase leads to competition with its substrates PARIS and ARTS
por: Bendikov-Bar, Inna, et al.
Publicado: (2014) -
Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice
por: Migdalska‐Richards, Anna, et al.
Publicado: (2016) -
Misfolding of Lysosomal α-Galactosidase a in a Fly Model and Its Alleviation by the Pharmacological Chaperone Migalastat
por: Braunstein, Hila, et al.
Publicado: (2020) -
Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate
por: Migdalska‐Richards, Anna, et al.
Publicado: (2017) -
Unfolded protein response in Gaucher disease: from human to Drosophila
por: Maor, Gali, et al.
Publicado: (2013)